Hana Pharm Co., Ltd.

₩8,110As of Sun 8 Nov 2026, 12:00 UTC
KRX:293480Healthcare
Country South Korea
PE (Fwd) •••
TSR 8Y CAGR (8.20%)
Div yield 6.29%
ROE 35.53%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.33
PE TTM 3.616
TSR TTM (27.95%)
Mkt cap ₩144.1B
ROIC 28.20%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩9,294
14.60%
25.53%
Hold 2|6|11|0|11
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
181.66
185.54
177.85
186.04
16.98%
13.62%
3.51%
0.13%
Revenue₩B
11.12
10.83
10.63
10.94
8.99%
1.06%
0.14%
(1.80%)
Peers (US$106.3M)
Cap (US$)
PE
106.9M
26.43x
105.2M
7.897x
Capital
TTM
5Y
10Y
Leveragex
0.825
(0.098)
(0.065)
EBIT/Intx
0.965
1.010
0.733
Own earn%
(1.30)
6.40
5.25
Sh yield%
31.23
29.84
29.88
Owners
Insiders/Inst%
13.64
38.53
Short interest%
2.45
SBC / revenue%
5.33
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
30–36
$1 testx
−0.1
Incr. ROIC%
142